Storage of RBCs results in an increased susceptibility for complement-mediated degradation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25492040)

Published in Transfus Med on December 10, 2014

Authors

J Kamhieh-Milz1, B Bartl, V Sterzer, S Kamhieh-Milz, A Salama

Author Affiliations

1: Institute for Transfusion Medicine, Charité University Medical Centre, Berlin, Germany.

Articles by these authors

(truncated to the top 100)

Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med (1994) 2.78

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40

Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab). Br J Haematol (2001) 1.66

The effect of the diameter of metal-on-metal bearings on systemic exposure to cobalt and chromium. J Bone Joint Surg Br (2006) 1.52

Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest (2005) 1.50

Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet (1983) 1.31

Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol (1984) 1.11

Diagnosis of gonococcal infection in high risk women using a rapid test. Sex Transm Infect (2006) 1.10

Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion (1987) 1.00

Percutaneous management of renal calculi: experience with percutaneous nephrolithotomy in 60 children. J Urol (1999) 0.98

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann Rheum Dis (2008) 0.96

Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4) Lancet (1999) 0.95

Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev (1990) 0.95

Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion (1984) 0.95

Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura. Hematology (2009) 0.95

Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis (1999) 0.94

Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol (1999) 0.93

Immune hemolysis-serological and clinical aspects. Clin Exp Med (2003) 0.93

Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D). Blut (1984) 0.93

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol (2001) 0.92

The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med (1985) 0.91

Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. J Neurol (2001) 0.91

Desipramine reversal of chloroquine resistance in wild isolates of Plasmodium falciparum. Lancet (1990) 0.90

Management of alloimmune thrombocytopenia. Vox Sang (2007) 0.89

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome. Ann Rheum Dis (2008) 0.88

Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang (1998) 0.87

Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens (1995) 0.87

Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D). Eur J Pediatr (1986) 0.86

Vesicouterine fistula--variable clinical presentation. Scand J Urol Nephrol (1996) 0.86

Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor. Transfusion (2001) 0.86

Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol (1985) 0.85

Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol (2008) 0.85

Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang (1990) 0.85

Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing. Hum Immunol (1996) 0.84

Management of the oral and maxillofacial surgery patient with thrombocytopenia. J Oral Maxillofac Surg (2001) 0.84

Paradoxical findings in direct antiglobulin test and classification of agglutinating autoantibodies using eluates and monospecific anti-human globulin sera. Vox Sang (2014) 0.83

Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients. J Clin Pharm Ther (2007) 0.83

Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem (1990) 0.83

Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield. Transfusion (2000) 0.83

Detection of a new weak A blood-group allele (Aw11). Vox Sang (2006) 0.81

6th International Immunoglobulin Symposium: poster presentations. Clin Exp Immunol (2009) 0.81

Deposition of the terminal C5b-9 complement complex on erythrocytes by human red cell autoantibodies. Br J Haematol (1983) 0.81

Autoimmune hemolytic anemia associated with an IgA autoanti-Gerbich. Vox Sang (1990) 0.81

Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol (2001) 0.81

Sequence analysis of the 2nd intron revealed common sequence motifs providing the means for a unique sequencing based typing protocol of the HLA-A locus. Tissue Antigens (1996) 0.80

Autoimmune haemolytic anaemia in childhood associated with non-complement binding IgM autoantibodies. Br J Haematol (1987) 0.80

Red cell function of carp (Cyprinus carpio) in acute hypoxia. Exp Biol (1987) 0.80

Increased RBC autoantibody production in pregnancy. Transfusion (2001) 0.80

Identification and characterization of a novel HLA-DRB1 allele, DRB1*0830*. Tissue Antigens (2005) 0.80

Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol (1986) 0.80

A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping. Vox Sang (2006) 0.80

Amlodipine-induced immune thrombocytopenia. Vox Sang (2004) 0.80

Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant. Vox Sang (2002) 0.79

Simultaneous genotyping of human platelet antigens (HPA) 1 through 6 using new sequence-specific primers for HPA-5. Transfusion (2000) 0.79

Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Adv Exp Med Biol (2000) 0.79

Binding of fluid phase C3b to nonsensitized bystander human red cells. A model for in vivo effects of complement activation on blood cells. Transfusion (1985) 0.79

ELISA methods detect HLA antibodies with variable sensitivity. Int J Immunogenet (2006) 0.79

Quantitative evaluation of elution methods for red cell antibodies. Vox Sang (1984) 0.78

Impact of the Gulf war on congenital heart diseases in Kuwait. Int J Cardiol (2004) 0.78

Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication. Vox Sang (2004) 0.78

Optimum storage conditions for cord blood-derived hematopoietic progenitor cells prior to isolation. Bone Marrow Transplant (2007) 0.78

Evidence suggesting the occurrence of C3-independent intravascular immune hemolysis. Reactive hemolysis in vivo. Transfusion (1987) 0.78

Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion (1999) 0.78

B*4440: a novel HLA-B allele identified by sequence-specific oligonucleotide hybridization and sequence-specific amplification. Tissue Antigens (2005) 0.78

[Preoperative identification of patients with impaired (primary) haemostasis. A practical concept]. Hamostaseologie (2007) 0.78

Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol (1986) 0.78

The clinical significance of HLA antigens on red cells. Survival studies in HLA-sensitized individuals. Transfusion (1985) 0.78

Rapid typing of the human neutrophil antigen 1a by the particle gel agglutination assay. Tissue Antigens (2009) 0.77

Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol (1997) 0.77

Description of a novel HLA-B allele, B*5613, identified during HLA-typing using sequence-specific oligonucleotide hybridization and sequence-specific amplification. Tissue Antigens (2004) 0.77

Regulation of ion transport across lamprey (Lampetra fluviatilis) erythrocyte membrane by oxygen tension. J Exp Biol (1998) 0.77

Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation. Ophthalmologica (1977) 0.77

Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil. Transfus Med (2010) 0.77

Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura. Hematology (2007) 0.77

Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry. Transfus Med (2002) 0.77

Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator. Transfusion (2003) 0.77

Antibodies against protein Z and fetal loss: current perspectives. Clin Exp Med (2005) 0.76

Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med (2000) 0.76

Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells. Stem Cells (2004) 0.76

Identification of the novel HLA-A*240215 allele by haplotype-specific sequencing. Tissue Antigens (2008) 0.76

IgG therapy in autoimmune haemolytic anaemia of warm type. Blut (1984) 0.76

Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease. J Drug Target (2010) 0.76

Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat. Neurosci Lett (1989) 0.76

On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood (1987) 0.76

Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome. Clin Cancer Res (2000) 0.76

Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques. Bone Marrow Transplant (1998) 0.76

CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia. Transfus Med (2006) 0.76

Identification of a novel HLA-B allele, HLA-B*5529, by haplotype-specific sequencing. Tissue Antigens (2008) 0.76

A two-stage immunoradiometric assay with 125I-staphylococcal protein A for the detection of antibodies and complement on human blood cells. Vox Sang (1985) 0.76

A novel HLA-A*680104 variant. Tissue Antigens (2006) 0.75

Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatr Blood Cancer (2006) 0.75

A novel HLA-B*270509 variant escaping detection by PCR-SSO-based histotyping. Tissue Antigens (2005) 0.75

Haplotype-specific sequencing reveals a novel HLA-B*37 allele, B*3714. Tissue Antigens (2008) 0.75

Identification of a novel HLA-DQB1 allele, HLA-DQB1*0632. Tissue Antigens (2007) 0.75

Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol (2002) 0.75

Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect? Int J Cardiol (1999) 0.75

The diversity of the HLA class I introns reflects the serological relationship of the coding regions. Beitr Infusionsther Transfusionsmed (1997) 0.75

Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand J Immunol (1999) 0.75

[Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility]. Z Geburtshilfe Neonatol (2000) 0.75

An extended lymphocytotoxicity test for patients treated with lymphocytotoxic antibodies. Vox Sang (2000) 0.75